Cleared Traditional

Auxilock GFS Mini, GFS II Large, and GFS Ultimate (K213018) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K213018 · Auxein Medical Private Limited · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2022
Decision
424d
Days
Class 2
Risk

K213018 is an FDA 510(k) clearance for the Auxilock GFS Mini, GFS II Large, and GFS Ultimate. Classified as Fastener, Fixation, Nondegradable, Soft Tissue within the MBI classification (a category for soft tissue fixation fasteners and anchoring systems), Class II - Special Controls.

Submitted by Auxein Medical Private Limited (Sonipat, IN). The FDA issued a Cleared decision on November 18, 2022 after a review of 424 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3040 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Orthopedic submissions.

View all Auxein Medical Private Limited devices

Submission Details

510(k) Number K213018 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 20, 2021
Decision Date November 18, 2022
Days to Decision 424 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
302d slower than avg
Panel avg: 122d · This submission: 424d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MBI Fastener, Fixation, Nondegradable, Soft Tissue
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3040
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MBI Fastener, Fixation, Nondegradable, Soft Tissue

All 321
Devices cleared under the same product code (MBI) and FDA review panel - the closest regulatory comparables to K213018.
Arthrex FiberTak Suture Anchor
K221396 · Arthrex, Inc. · Dec 2022
AUXILOCK PEEK OPTIMA Screw-In Suture Anchor, AUXILOCK ROTADOR PEEK OPTIMA Screw-In Anchor
K213110 · Auxein Medical Private Limited · Dec 2022
Aevumed PHANTOM™-LP Suture Anchors
K222363 · Aevumed, Inc. · Nov 2022
Responsive Arthroscopy Mustang and Mustang Knotless Suture Anchors
K222763 · Responsive Arthroscopy, LLC · Oct 2022
WasherCap Fixation System
K212197 · Abanza Tecnomed S.L · Sep 2022
Grappler Suture Anchor System
K222091 · Paragon 28, Inc. · Sep 2022